With 30% of COPD cases misdiagnosed, experts call for improved diagnostic strategies, better disease classification, and ...

Medically reviewed by Brian Bezack, DO Over-the-counter (OTC) inhalers are not approved for treating chronic obstructive ...

Verona Pharma has blockbuster hopes for its recently approved drug for chronic obstructive pulmonary disorder (COPD), and preliminary sales figures for the drug suggest it is heading in the right ...

Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.

and so it is not yet clear if the effect of the drug had to do with the weight loss and its effect on COPD, or it had a different mechanism of action. “There’s a lot of hype and excitement ...

A person can get a COPD inhaler through Medicare Part D or a Medicare Advantage Prescription Drug (MAPD) plan. People enrolled in Original Medicare (parts A and B) can add Medicare Part D ...

The higher prices of two COPD inhalers from GSK that are targeted in the second round of government drug price negotiations ...

People with COPD experience more falls and related injuries ... Of the 8,204 people, 65% were prescribed at least one fall-risk increasing drug, and 30% had a fall with injury in the two years ...

The Institute for Clinical and Economic Review has prepared a special report on Trelegy and Breo, two therapies that treat ...